Large phase 3 trials, such as the SURPASS series (focused on glucose control) and the SURMOUNT program (focused on obesity), have shaped clinician confidence in tirzepatide by showing meaningful improvements in A1c and clinically significant weight loss compared with placebo
The reasons for this sex difference are not fully understood, but might have to do with slower clearance of the drug, or potential synergies between estrogen and GLP-1 signaling
Lasram MM, Dhouib IB, Annabi A, El Fazaa S, Gharbi N
Antihistamines, allergen immunotherapy and allergic emergencies BNF NICE
Total proteins from lysed cells or patient tissue were extracted using RIPA lysis buffer and electrophoresed by SDS-PAGE and transferred onto PVDF membranes subsequently
Individual responses vary based on the specific medication, dose, and personal gastrointestinal physiology